Robert E Conway - Net Worth and Insider Trading
Robert E Conway Net Worth
The estimated net worth of Robert E Conway is at least $29 Million dollars as of 2024-04-25. Robert E Conway is the CEO of Array BioPharma Inc and owns about 656,196 shares of Array BioPharma Inc (ARRY) stock worth over $26 Million. Robert E Conway is the Director of Alpine Immune Sciences Inc and owns about 50,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $3 Million. Robert E Conway is also the Chairman of the Board of ARCA biopharma Inc and owns about 50,000 shares of ARCA biopharma Inc (ABIO) stock worth over $174,000. Details can be seen in Robert E Conway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert E Conway has not made any transactions after 2021-09-23 and currently still holds the listed stock(s).
Transaction Summary of Robert E Conway
Robert E Conway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E Conway owns 2 companies in total, including ARCA biopharma Inc (ABIO) , and Alpine Immune Sciences Inc (ALPN) .
Click here to see the complete history of Robert E Conway’s form 4 insider trades.
Insider Ownership Summary of Robert E Conway
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABIO | ARCA biopharma Inc | 2021-05-12 | director |
| ALPN | Alpine Immune Sciences Inc | 2021-09-23 | director |
Robert E Conway Latest Holdings Summary
Robert E Conway currently owns a total of 3 stocks. Among these stocks, Robert E Conway owns 656,196 shares of Array BioPharma Inc (ARRY) as of June 17, 2011, with a value of $26 Million and a weighting of 88.24%. Robert E Conway owns 50,000 shares of Alpine Immune Sciences Inc (ALPN) as of September 23, 2021, with a value of $3 Million and a weighting of 11.16%. Robert E Conway also owns 50,000 shares of ARCA biopharma Inc (ABIO) as of May 12, 2021, with a value of $174,000 and a weighting of 0.6%.
Latest Holdings of Robert E Conway
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARRY | Array BioPharma Inc | 2011-06-17 | 656,196 | 38.95 | 25,558,834 |
| ALPN | Alpine Immune Sciences Inc | 2021-09-23 | 50,000 | 64.63 | 3,231,500 |
| ABIO | ARCA biopharma Inc | 2021-05-12 | 50,000 | 3.48 | 174,000 |
Holding Weightings of Robert E Conway
Robert E Conway Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E Conway has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the acquisition of 25,000 shares on June 17, 2011, which cost Robert E Conway around $54,250.
According to the SEC Form 4 filings, Robert E Conway has made a total of 4 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Alpine Immune Sciences Inc is the sale of 15,000 shares on September 23, 2021, which brought Robert E Conway around $151,200.
According to the SEC Form 4 filings, Robert E Conway has made a total of 5 transactions in ARCA biopharma Inc (ABIO) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in ARCA biopharma Inc is the acquisition of 10,000 shares on May 12, 2021, which cost Robert E Conway around $31,900.
Insider Trading History of Robert E Conway
- 1
Robert E Conway Trading Performance
GuruFocus tracks the stock performance after each of Robert E Conway's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E Conway is -1.38%. GuruFocus also compares Robert E Conway's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E Conway within 3 months outperforms 4 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert E Conway's insider trading performs compared to the benchmark.
Performance of Robert E Conway
Average Return
-24.1%
Outperforming Transactions
18%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.45 | -1.38 | -6.73 | -24.1 | -15.97 | -22.92 |
| Relative Return to S&P 500(%) | -1.36 | -5.89 | -15.41 | -36.49 | -23.3 | -31.33 |
Robert E Conway Ownership Network
Ownership Network List of Robert E Conway
Ownership Network Relation of Robert E Conway
Robert E Conway Owned Company Details
What does ARCA biopharma Inc do?
Who are the key executives at ARCA biopharma Inc?
Robert E Conway is the director of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .
ARCA biopharma Inc (ABIO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARCA biopharma Inc Insider Transactions
Robert E Conway Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E Conway. You might contact Robert E Conway via mailing address: C/o Arca Biopharma, Inc, 8001 Arista Place, Ste 430, Broomfield Co 80021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
